| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |